查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2075118

Betamethasone倍他米松市場：按劑型、給藥途徑、應用、年齡層、分銷管道和地區分類的市場規模、佔有率、前景和機會分析（2025-2032 年）

Betamethasone Acetate Market, by Formulation, by Route of Administration, by Application, by Age Group, by Distribution Channel, by Region Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年，Betamethasone倍他米松市場規模將達到 5.088 億美元，到 2033 年將達到 7.16 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 5.0%。

報告範圍 報告詳情
基準年： 2025 2026年市場規模： 5.088億美元
歷史數據時期： 2020年至2024年 預測期： 2026年至2033年
2026年至2033年預測期間的複合年成長率： 5.00% 2033年市場規模預測： 7.16億美元

Betamethasone米松可分為乙酸酯、甾類酯、17α-羥基甾類、20-Oxo甾類、氟代甾類、11BETA-羥基甾類、3-氧代Δ(1),Δ(4)-甾類及叔α-羥基酮。其功能與Betamethasone相關。

Betamethasone是一種長效型糖皮質激素，具有抗發炎和免疫抑製作用。它可用於治療多種疾病，包括自體免疫疾病，也可局部治療濕疹等發炎性皮膚病。Betamethasone他米松鈉和醋酸Betamethasone米松注射懸浮液也可用於治療筋膜和肌腱的囊性腫瘤（神經節囊腫）。Betamethasone注射懸浮液用於治療多種疾病引起的發炎和疼痛，包括多發性硬化症和關節炎。

市場動態

由於醋酸Betamethasone用於治療多種疾病，包括腎臟疾病，因此腎臟病盛行率的不斷上升預計將在預測期內推動市場成長。例如，根據美國疾病管制與預防中心 (CDC) 2022 年 7 月提供的數據，估計 2020 年美國超過 15% 的成年人（即 3700 萬人）患有慢性腎臟病(CKD)。此外，根據相同資訊來源，CKD 在 65 歲及以上人群中的發生率 (38%) 高於 45-64 歲 (12%) 或 18-44 歲 (6%) 的人群。

由於醋酸Betamethasone用於治療多種疾病，包括呼吸系統疾病，因此呼吸系統疾病盛行率的不斷上升預計將在預測期內推動醋酸Betamethasone市場的成長。例如，根據世界衛生組織（WHO）2021年8月的報告，2020年約有6500萬人患有中度至重度慢性阻塞性肺病（COPD），佔全球整體所有死亡人數的5%（每10萬人中有41.9人死亡）。

本研究的主要特點：

  • 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及領先企業採取的競爭策略。
  • 本研究基於以下參數，對全球倍他米松醋酸Betamethasone市場的主要參與者進行了概況分析：公司概況、產品系列、關鍵亮點、財務績效和策略。本研究涵蓋的主要參與者包括：默克公司 (Merck & Co., Inc.)、美國瑞金公司 (American Regent, Inc.)、麥克森醫療外科公司 (McKesson Medical-Surgical Inc.)、GNHIndia.com、Lexicon Medical Supply、Medline Industries, Inc.、Caspian Tamin Pharmaceutical Co.、MedzS. Inc.、Medisca Inc.、Exela Pharma Sciences, LLC、賽諾菲巴斯德公司 (Sanofi Pasteur Inc.) 和 Sorrento Therapeutics Inc.。
  • 本報告提供的見解將有助於各公司的行銷負責人和經營團隊就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 全球倍他米松醋酸Betamethasone市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用分析全球倍他米松Betamethasone市場中使用的各種策略矩陣來簡化決策過程。

目錄

第1章：研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場吸引力分析
    • 市場機遇
  • 產品發布
  • 併購和合作
  • 監管準則與合規性
  • 主要進展
  • PEST分析
  • 科技趨勢
  • 波特的分析
  • 價格分析（2022）

第4章 全球Betamethasone倍他米松市場：以劑型分類，2021-2033年

  • 懸浮液
  • 軟膏
  • 凝膠

第5章 全球Betamethasone倍他米松市場：依給藥途徑分類，2021-2033年

  • 肌肉內部
  • 關節內
  • 皮內給藥

第6章 全球Betamethasone倍他米松市場：依應用領域分類，2021-2033年

  • 呼吸系統疾病
  • 腎臟疾病
  • 消化系統疾病
  • 眼科疾病
  • 皮膚病
  • 其他

第7章 全球Betamethasone倍他米松市場：依年齡層別分類，2021-2033年

  • 兒童
  • 老年人

第8章 全球Betamethasone倍他米松市場：依通路分類，2021-2033年

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第9章 全球Betamethasone倍他米松市場：依地區分類，2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第10章 競爭格局

  • Merck & Co., Inc.
  • American Regent, Inc.
  • McKesson Medical-Surgical Inc.
  • GNHIndia.com
  • Lexicon Medical Supply
  • Medline Industries, Inc.
  • Caspian Tamin Pharmaceutical Co.
  • Sandoz Canada Inc.
  • NorthWestPharmacy.com Inc.
  • Medisca Inc.
  • Exela Pharma Sciences, LLC
  • Sanofi Pasteur Inc.
  • Sorrento Therapeutics Inc.

第11章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI5481

Betamethasone Acetate Market is estimated to be valued at USD 508.8 Mn in 2026 and is expected to reach USD 716.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.0% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 508.8 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 5.00% 2033 Value Projection: USD 716.0 Mn

Betamethasone acetate is an acetate ester, a steroid ester, a 17alpha-hydroxy steroid, a 20-oxo steroid, a fluorinated steroid, an 11beta-hydroxy steroid, a 3-oxo-Delta (1), Delta (4)-steroid and a tertiary alpha-hydroxyl ketone. It is functionally related to a betamethasone.

Betamethasone acetate is long-acting corticosteroid has anti-inflammatory and immunosuppressive effects. It can be administered parenterally to treat a number of disease states, including autoimmune illnesses, and topically to treat inflammatory skin conditions including eczema. Betamethasone sodium phosphate and betamethasone acetate injectable suspension may also be useful in cystic tumors of an aponeurosis or tendon (ganglia). Betamethasone injectable suspension is used to treat inflammation and pain from a variety of conditions. These conditions include multiple sclerosis, arthritis, and others.

Market Dynamics

The betamethasone acetate is used in various disease conditions such as renal disease, thus the increasing prevalence of renal disease is expected to drive the market growth over the forecast period. For instance, in July 2022, according to data provided by Center of Disease Control and Prevention (CDC), in 2020, more than 15% of the U.S. adults or 37 million people, are estimated to have Chronic Kidney Disease (CKD). Moreover, according to same source CKD is more common in people aged 65 years or older (38%) than in people aged 45-64 years (12%) or 18-44 years (6%).

The betamethasone acetate is used in various disease condition such as respiratory diseases, thus the increasing prevalence of respiratory disease is expected to drive the betamethasone acetate market growth over the forecast period. For instance, in August 2021, according to the World Health Organization (WHO), in 2020 approximately, 65 million people had moderate to severe Chronic Obstructive Pulmonary Diseases (COPD) that accounts for 5% of deaths (41.9 deaths per 100 000 individuals) globally.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global betamethasone acetate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Merck & Co., Inc., American Regent, Inc., McKesson Medical-Surgical Inc., GNHIndia.com, Lexicon Medical Supply, Medline Industries, Inc., Caspian Tamin Pharmaceutical Co., Sandoz Canada Inc, NorthWestPharmacy.com Inc., Medisca Inc, Exela Pharma Sciences, LLC, Sanofi Pasteur Inc., Sorrento Therapeutics Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global betamethasone acetate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global betamethasone acetate market

Detailed Segmentation:

  • Global Betamethasone Acetate Market, By Formulation (Revenue, USD Mn, 2021 - 2033)
  • Suspension
  • Ointment
  • Gel
  • Global Betamethasone Acetate Market, By Route of Administration (Revenue, USD Mn, 2021 - 2033)
  • Intramuscular
  • Intra-articular
  • Intradermal
  • Global Betamethasone Acetate Market By Application (Revenue, USD Mn, 2021 - 2033)
  • Respiratory Disease
  • Renal Disease
  • Gastrointestinal Disease
  • Ophthalmic Disease
  • Dermatological Disease
  • Others
  • Global Betamethasone Acetate Market By Age Group (Revenue, USD Mn, 2021 - 2033)
  • Pediatric
  • Geriatric
  • Global Betamethasone Acetate Market By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Betamethasone Acetate Market, By Region (Revenue, USD Mn, 2021 - 2033)
  • North America
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
  • Merck & Co., Inc.*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • American Regent, Inc.
  • McKesson Medical-Surgical Inc.
  • GNHIndia .com
  • Lexicon Medical Supply
  • Medline Industries, Inc.
  • Caspian Tamin Pharmaceutical Co.
  • Sandoz Canada Inc
  • NorthWestPharmacy.com Inc.
  • MEDISCA PHARMACEUTIQUE INC
  • Exela Pharma Sciences, LLC
  • Sanofi Pasteur Inc.
  • Sorrento Therapeutics Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Formulation
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Application
    • Market Snapshot, By Age Group
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Attractiveness Analysis
    • Market Opportunities
  • Product Launches
  • Merger, Acquisition, Collaborations
  • Regulatory Guideline and Compliances
  • Key Developments
  • PEST Analysis
  • Technology Landscape
  • PORTER's Analysis
  • Pricing Analysis (2022)

4. Global Betamethasone Acetate Market, By Formulation, 2021 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Suspension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
  • Ointment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
  • Gel
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

5. Global Betamethasone Acetate Market, By Route of Administration, 2021 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Intramuscular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
  • Intra-articular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
  • Intradermal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

6. Global Betamethasone Acetate Market, By Application, 2021 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segments Trends
  • Respiratory Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
  • Renal Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
  • Gastrointestinal Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
  • Ophthalmic Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
  • Dermatological Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

7. Global Betamethasone Acetate Market, By Age Group, 2021 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segments Trends
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
  • Geriatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

8. Global Betamethasone Acetate Market, By Distribution Channel, 2021 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segments Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

9. Global Betamethasone Acetate Market, By Region, 2021 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2022-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Million)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • American Regent, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • McKesson Medical-Surgical Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GNHIndia.com
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Lexicon Medical Supply
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medline Industries, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Caspian Tamin Pharmaceutical Co.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sandoz Canada Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • NorthWestPharmacy.com Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medisca Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Exela Pharma Sciences, LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi Pasteur Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sorrento Therapeutics Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

11. Section

  • Research Methodology
  • About Us